Diaceutics PLC (AIM: DXRX)
London
· Delayed Price · Currency is GBP · Price in GBX
125.50
+0.50 (0.40%)
Dec 20, 2024, 11:18 AM GMT+1
Diaceutics Cash Flow Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | -2.85 | -1.75 | 0.72 | 0.56 | 0.26 | 0.4 | Upgrade
|
Depreciation & Amortization | 3.69 | 3.27 | 1.66 | 1.02 | 0.7 | 0.2 | Upgrade
|
Other Amortization | 1.42 | 1.5 | 1.35 | 0.78 | 0.11 | 0.08 | Upgrade
|
Loss (Gain) From Sale of Assets | 0 | 0 | - | - | - | - | Upgrade
|
Stock-Based Compensation | 0.67 | 0.45 | 0.54 | 0.37 | 0.29 | 0.02 | Upgrade
|
Other Operating Activities | -2.7 | -0.62 | 1.16 | -0.51 | -1.6 | 0.16 | Upgrade
|
Change in Accounts Receivable | -0.59 | -2.16 | -1.59 | -1.5 | 0.55 | -2.32 | Upgrade
|
Change in Accounts Payable | 2.11 | 0.62 | 1.27 | -0.16 | -0.06 | 0.83 | Upgrade
|
Operating Cash Flow | 1.77 | 1.31 | 5.1 | 0.57 | 0.25 | -0.63 | Upgrade
|
Operating Cash Flow Growth | -30.24% | -74.27% | 794.04% | 125.30% | - | - | Upgrade
|
Capital Expenditures | -0.13 | -0.13 | -0.19 | -0.57 | -0.14 | -0.1 | Upgrade
|
Sale (Purchase) of Intangibles | -3.23 | -4.73 | -4.68 | -5.04 | -6.16 | -2.83 | Upgrade
|
Other Investing Activities | 0.74 | 0.65 | 0.11 | - | - | 0 | Upgrade
|
Investing Cash Flow | -2.61 | -4.21 | -4.76 | -5.6 | -6.29 | -2.92 | Upgrade
|
Long-Term Debt Issued | - | - | - | - | - | 0.96 | Upgrade
|
Long-Term Debt Repaid | - | -0.18 | -0.16 | -0.05 | - | -3.45 | Upgrade
|
Net Debt Issued (Repaid) | -0.18 | -0.18 | -0.16 | -0.05 | - | -2.5 | Upgrade
|
Issuance of Common Stock | 0.14 | - | 0.13 | - | 19.61 | 16.04 | Upgrade
|
Repurchase of Common Stock | -0.02 | -0.05 | -0.1 | -0.17 | - | - | Upgrade
|
Other Financing Activities | 0 | -0.01 | -0.06 | -0.06 | - | -0.25 | Upgrade
|
Financing Cash Flow | -0.06 | -0.24 | -0.19 | -0.27 | 19.61 | 13.29 | Upgrade
|
Foreign Exchange Rate Adjustments | -0.22 | -0.04 | 0.02 | -0.28 | -0.04 | -0.09 | Upgrade
|
Net Cash Flow | -1.13 | -3.17 | 0.17 | -5.58 | 13.54 | 9.65 | Upgrade
|
Free Cash Flow | 1.64 | 1.19 | 4.91 | 0.01 | 0.12 | -0.73 | Upgrade
|
Free Cash Flow Growth | -29.88% | -75.85% | 98100.00% | -95.69% | - | - | Upgrade
|
Free Cash Flow Margin | 6.28% | 5.00% | 25.17% | 0.04% | 0.91% | -5.42% | Upgrade
|
Free Cash Flow Per Share | 0.02 | 0.01 | 0.06 | 0.00 | 0.00 | -0.01 | Upgrade
|
Cash Interest Paid | - | 0.01 | 0.06 | 0.06 | - | 0.25 | Upgrade
|
Cash Income Tax Paid | 1.07 | -0.69 | -1.39 | 0.33 | 0.43 | 0.02 | Upgrade
|
Levered Free Cash Flow | 1.41 | -1.18 | -0.35 | -5.55 | -6.39 | -2.89 | Upgrade
|
Unlevered Free Cash Flow | 1.44 | -1.14 | -0.28 | -5.49 | -6.36 | -2.75 | Upgrade
|
Change in Net Working Capital | -1.69 | -0.29 | -0.6 | 2.46 | 1 | 1.43 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.